Hear an update from this CED Showcase Alumni at the conference!
Recent Company News: Locus Biosciences lands $19M in funding for gene editing technology (WRAL TechWire)
Paul has been a member of multiple Executive Management teams of both publicly traded multi-national corporations and successful startup opportunities. He currently serves as the CEO of Locus Biosciences, an emerging biotech focused on the discovery and development of a novel class of CRISPR/Cas Antimicrobials.
Paul also serves as Vice President of the Friends Board at the North Carolina Museum of Natural Sciences, and as a Visiting Professor at North Carolina State University’s Poole College of Management. He serves as an executive-in-residence for the HiTEC Graduate Program, the University’s Entrepreneurship Collaborative.
Join Paul at the CED Life Science Conference 2018.